BIOLIFE4D: Bioprinted Mini-Heart Addresses a $7B+ Market Opportunity

May. 6, 2022
BIOLIFE4D is an emerging biotech company focused on leveraging advances in life sciences, bioengineering, computational medicine, and additive manufacturing technologies to 3D bioprint viable human cardiac components. BIOLIFE4D is committed to perfecting the technology to make viable organ replacement a safe, accessible, and affordable reality. Visit to learn more.

 Read More

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market